Excelya
Private Company
Total funding raised: $25M
Overview
Excelya is a mid-sized, global contract research organization (CRO) headquartered in Paris, France, offering a full suite of clinical development services. The company differentiates itself through a flexible three-pillar business model (Full Service, FSP, Resourcing), deep therapeutic expertise, and a stated culture of 'Audacity, Care, and Energy.' With a network of experts across 25 countries and experience in over 550 clinical studies, Excelya positions itself as an agile partner capable of providing senior-level attention and tailored solutions for biotech and pharmaceutical clients.
Technology Platform
Integrated clinical development service platform organized into Centers of Excellence (Clinical Ops, Data Management, Stats & Programming, Pharmacovigilance, Medical Affairs, eTMF, Regulatory, QA). Leverages industry-standard EDC systems, 100% digital eTMF, and holds ISO 27001 certification for data security. Partnered with Veeva.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Operates in the highly competitive global CRO market, competing against large public players (e.g., IQVIA, ICON, LabCorp) and numerous mid-sized and specialty CROs. Differentiates through a flexible three-model service offering, mid-size agility providing senior attention, and deep therapeutic expertise in areas like oncology and rare diseases.